Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Feb 1, 2021
Posted in: Investor updates

Home » Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Feb 1, 2021
Posted in: Investor updates

The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 1 February, 2021.

Please click to review the full announcement at ASX.

[VIDEO] EGM Recording – 13 November 2023

November 14, 2023

https://youtu.be/hThLkmpJPW0 EGM 13 November 2023 Video transcript: Welcome and thanks for joining us. Both those joining virtually and those in person. As the time is

Quarterly Activity Report – Quarter ending 30 September 2023

October 31, 2023

Highlights: Announced preliminary performance of MagSense® HER2 Imaging Agent in phase 1 study after study closure (post quarter end) Entered a strategic partnership with Prestige

[VIDEO] 2023 EGM Resolution Overview

October 24, 2023

Earlier this month, Imagion announced our upcoming EGM meeting to be held on 13th November, along with several resolutions to be voted on by shareholders. Here, Imagion

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Related Articles

[VIDEO] EGM Recording – 13 November 2023

Quarterly Activity Report – Quarter ending 30 September 2023

[VIDEO] 2023 EGM Resolution Overview

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list